Filing Details
- Accession Number:
- 0001104659-22-124566
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-05 16:13:38
- Reporting Period:
- 2022-12-05
- Accepted Time:
- 2022-12-05 16:13:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1390478 | Sellas Life Sciences Group Inc. | SLS | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1568734 | Thomas John Burns | C/O Sellas Life Sciences Group, Inc., 7 Times Square, Suite 2503 New York NY 10036 | Senior Vp, Finance & Cao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2022-12-05 | 1,159 | $2.59 | 29,347 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the number shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
Billionaire Hedge Funds
